Published online before print February 7, 2002, doi: 10.1161/01.RES.0000012460.85923.F0
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 30, 2001
Revised on January 23, 2002
Accepted on January 25, 2002
Brain-Selective Overexpression of Angiotensin (AT1) Receptors Causes Enhanced Cardiovascular Sensitivity in Transgenic Mice
Eric Lazartigues ;
From the Department of Anatomy and Cell Biology (E.L., S.M.D., A.K.L., P.S., J.A.L., J.J.E., R.L.D.) and the Departments of Internal Medicine and Physiology and Biophysics (C.D.S.), the University of Iowa College of Medicine, Iowa City, Iowa.
* To whom correspondence should be addressed. E-mail: robin-davisson{at}uiowa.edu.
To examine the physiological importance of brain angiotensin II type 1 (AT1) receptors, we developed a novel transgenic mouse model with rat AT1a receptors targeted selectively to neurons of the central nervous system (CNS). A transgene consisting of 2.8 kb of the rat neuron-specific enolase (NSE) 5' flanking region fused to a cDNA encoding the full open-reading frame of the rat AT1a receptor was constructed and transgenic mice (NSE-AT1a) were generated. Two of six transgenic founder lines exhibited brain-selective expression of the transgene at either moderate or high levels. Immunohistochemistry revealed widespread distribution of AT1 receptors in neurons throughout the CNS. This neuron-targeted overexpression of AT1a receptors resulted in enhanced cardiovascular responsiveness to intracerebroventricular (ICV) angiotensin II (Ang II) injection but not to other central pressor agents, demonstrating functional overexpression of the transgene in NSE-AT1a mice. Interestingly, baseline blood pressure (BP) was not elevated in either transgenic line. However, blockade of central AT1 receptors with ICV losartan caused significant falls in basal BP in NSE-AT1a mice but had no effect in nontransgenic controls. These results suggest that whereas there is an enhanced contribution of central AT1 receptors to the maintenance of baseline BP in NSE-AT1a mice, particularly effective baroreflex buffering prevents hypertension in this model. Used both independently, and in conjunction with mice harboring gene-targeted deletions of AT1a receptors, this new model will permit quantitative and relevant investigations of the role of central AT1a receptors in cardiovascular homeostasis in health and disease.
Key words: renin-angiotensin system • blood pressure • hypertension • central nervous system • neurons
This article has been cited by other articles:
 |
|
 |
|
  E. Lazartigues, P. Sinnayah, G. Augoyard, C. Gharib, A. K. Johnson, and R. L. Davisson Enhanced water and salt intake in transgenic mice with brain-restricted overexpression of angiotensin (AT1) receptors Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2008; 295(5): R1539 - R1545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Grobe, D. Xu, and C. D. Sigmund An Intracellular Renin-Angiotensin System in Neurons: Fact, Hypothesis, or Fantasy Physiology, August 1, 2008; 23(4): 187 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Lin, Y. Chen, W. Zhang, A. F. Chen, S. Lin, and M. Morris RNA interference shows interactions between mouse brainstem angiotensin AT1 receptors and angiotensin-converting enzyme 2 Exp Physiol, May 1, 2008; 93(5): 676 - 684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Feng, X. Yue, H. Xia, S. M. Bindom, P. J. Hickman, C. M. Filipeanu, G. Wu, and E. Lazartigues Angiotensin-Converting Enzyme 2 Overexpression in the Subfornical Organ Prevents the Angiotensin II-Mediated Pressor and Drinking Responses and Is Associated With Angiotensin II Type 1 Receptor Downregulation Circ. Res., March 28, 2008; 102(6): 729 - 736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Mousa, D. Liu, K. G. Cornish, and I. H. Zucker Exercise training enhances baroreflex sensitivity by an angiotensin II-dependent mechanism in chronic heart failure J Appl Physiol, March 1, 2008; 104(3): 616 - 624. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Doobay, L. S. Talman, T. D. Obr, X. Tian, R. L. Davisson, and E. Lazartigues Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R373 - R381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Kistler, P. Sanders, M. Dodic, S. J. Spence, C. S. Samuel, C. Zhao, J. A. Charles, G. A. Edwards, and J. M. Kalman Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: implications for development of atrial fibrillation Eur. Heart J., December 2, 2006; 27(24): 3045 - 3056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. H. Zucker Novel Mechanisms of Sympathetic Regulation in Chronic Heart Failure Hypertension, December 1, 2006; 48(6): 1005 - 1011. [Full Text] [PDF]
|
|
|
|
|
|
R. A.L. Dampney Angiotensin Type 1A Receptors on Glial Cells in Rostral Ventrolateral Medulla and Hypertension Hypertension, June 1, 2006; 47(6): 1052 - 1053. [Full Text] [PDF]
|
|
|
|
|
|
Y. Chen, H. Chen, A. Hoffmann, D. R. Cool, D. I. Diz, M. C. Chappell, A. Chen, and M. Morris Adenovirus-Mediated Small-Interference RNA for In Vivo Silencing of Angiotensin AT1a Receptors in Mouse Brain Hypertension, February 1, 2006; 47(2): 230 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. H. Zucker and L. Gao The Regulation of Sympathetic Nerve Activity by Angiotensin II Involves Reactive Oxygen Species and MAPK Circ. Res., October 14, 2005; 97(8): 737 - 739. [Full Text] [PDF]
|
|
|
|
|
|
Y. Chen, H. Chen, and M. Morris Enhanced osmotic responsiveness in angiotensin AT1a receptor deficient mice: evidence for a role for AT1b receptors Exp Physiol, September 1, 2005; 90(5): 739 - 746. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Gao, W. Wang, Y.-L. Li, H. D. Schultz, D. Liu, K. G. Cornish, and I. H. Zucker Superoxide Mediates Sympathoexcitation in Heart Failure: Roles of Angiotensin II and NAD(P)H Oxidase Circ. Res., October 29, 2004; 95(9): 937 - 944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Lazartigues, A. J. Lawrence, F. S. Lamb, and R. L. Davisson Renovascular Hypertension in Mice With Brain-Selective Overexpression of AT1a Receptors Is Buffered by Increased Nitric Oxide Production in the Periphery Circ. Res., September 3, 2004; 95(5): 523 - 531. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sinnayah, T. E. Lindley, P. D. Staber, B. L. Davidson, M. D. Cassell, and R. L. Davisson Targeted viral delivery of Cre recombinase induces conditional gene deletion in cardiovascular circuits of the mouse brain Physiol Genomics, June 17, 2004; 18(1): 25 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Gardner, S. Pearce, J. Dandrea, R. Walker, M. M. Ramsay, T. Stephenson, and M. E. Symonds Peri-Implantation Undernutrition Programs Blunted Angiotensin II Evoked Baroreflex Responses in Young Adult Sheep Hypertension, June 1, 2004; 43(6): 1290 - 1296. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Wang, S. J. Veerasingham, J. Tan, and F. H. H. Leenen Effects of high salt intake on brain AT1 receptor densities in Dahl rats Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1949 - H1955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Davisson Physiological genomic analysis of the brain renin-angiotensin system Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2003; 285(3): R498 - R511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. D. Xiao, S. Fuchs, K. Frenzel, J. M. Cole, and K. E. Bernstein Newer Approaches to Genetic Modeling in Mice: Tissue-Specific Protein Expression as Studied Using Angiotensin-Converting Enzyme (ACE) Am. J. Pathol., September 1, 2003; 163(3): 807 - 817. [Full Text] [PDF]
|
|
|
|
|
|
J. Vazquez, C. Sun, J. Du, L. Fuentes, C. Sumners, and M. K. Raizada Transduction of a Functional Domain of the AT1 Receptor in Neurons by HIV-Tat PTD Hypertension, March 1, 2003; 41(3): 751 - 756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ehmke Mouse gene targeting in cardiovascular physiology Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2003; 284(1): R28 - R30. [Full Text] [PDF]
|
|
|
|
|
|
M. Dodic, T. Abouantoun, A. O'Connor, E. M. Wintour, and K. M. Moritz Programming Effects of Short Prenatal Exposure to Dexamethasone in Sheep Hypertension, November 1, 2002; 40(5): 729 - 734. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. H. Zucker Brain Angiotensin II: New Insights Into Its Role in Sympathetic Regulation Circ. Res., March 22, 2002; 90(5): 503 - 505. [Full Text] [PDF]
|
|